A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/506 (2006.01) A61P 7/06 (2006.01)
Patent
CA 2732791
Provided herein are method of treating, ameliorating, or delaying at least one symptom of a genetic blood disorder, e.g. sickle cell disorder or thalassemia, in a patient in need thereof, comprising administering a therapeutically effective amount of a Jak2 inhibitor. Also provided in part is a method of reducing an enlarged spleen in a patient suffering from thalassemia, comprising administering a therapeutically effective amount of a Jak2 inhibitor.
L'invention concerne un procédé de traitement, d'amélioration ou de retardement d'au moins un symptôme d'une affection génétique du sang, par exemple une affection liée aux drépanocytes ou une thalassémie, chez un patient le nécessitant, qui comprend l'administration d'une quantité thérapeutiquement efficace d'un inhibiteur de Jak2. Elle concerne également en partie un procédé de réduction d'une splénomégalie chez un patient souffrant de thalassémie, qui comprend l'administration d'une quantité thérapeutiquement efficace d'un inhibiteur de Jak2.
Mbm Intellectual Property Law Llp
Targegen Inc.
LandOfFree
Methods of treating thalassemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating thalassemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating thalassemia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1828240